Andere Sprachen United Therapeutics Corporation

Aktien

923818

US91307C1027

UTHR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
236 ^USD	-0,44 %		-0,41 %	+7,30 %

23.04.	United Therapeutics Insider verkaufte Aktien im Wert von $1.704.174, laut einer aktuellen SEC Einreichung	MT
19.04.	United Therapeutics Insider verkaufte Aktien im Wert von $1.704.990, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT	25.04.
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant	24.04.
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024	24.04.
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing	23.04.
United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says	23.04.
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing	19.04.
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing	17.04.
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference	16.04.
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing	15.04.
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing	11.04.
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing	09.04.
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing	05.04.
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing	04.04.
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension	01.04.
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling	01.04.
United Therapeutics Corporation Announces Extension of Credit Agreement	29.03.
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing	27.03.
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation	26.03.
United Therapeutics Corporation announces an Equity Buyback for $1,000 million worth of its shares.	25.03.
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing	25.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen United Therapeutics Corporation

Aktien

923818

US91307C1027

UTHR

Andere Sprachen

Filter